Study says therapeutics for trauma patients may not be effective due to an infection

Mar 16, 2010
Diana Hylton is a K-State senior in microbiology, nutritional sciences and premedicine. She is analyzing how the immune system is involved in damage to the intestines following hemorrhagic shock. Credit: Kansas State University

A Kansas State University study aimed at alleviating intestinal damage in trauma patients digressed to an important finding that could affect medication given to the individuals.

Diana Hylton is a K-State senior in microbiology, nutritional sciences and pre-medicine. She is analyzing how the immune system is involved in damage to the intestines following hemorrhagic shock. While studying the effects of a complement inhibitor given following hemorrhage, she found that Helicobacter infection changes the body's mechanistic response and would therefore affect the therapeutics given to .

"The understanding of the different immune processes involved after hemorrhage suggests that the therapeutic potential of some drugs might not be effective on trauma patients with undiagnosed Helicobacter infections," Hylton said.

Hylton is working with Sherry Fleming, assistant professor in the Division of Biology. Hylton's project involves studying a of hemorrhage, which is associated with a sudden rapid loss of a significant amount of blood, and it is common in trauma patients. Hemorrhage causes intestinal damage, and the body responds by activating the complement system.

The complement system is part of the body's natural immune mechanisms to defend against infections. However, uncontrolled and excessive activation can result in inflammatory tissue damage, so trauma victims are given therapeutics to stop the activation. If a therapeutic could stop complement activation briefly, trauma victims would get less and improved survival and recovery because the natural immune functions would remain intact.

Hylton has been analyzing changes in the mouse model concerning the intestinal tissue injury and inflammatory response. During the study, the mice became infected with Helicobacter, which is a bacteria found in the intestines of animals and humans. The infection often does not show obvious symptoms and therefore is commonly undiagnosed, which causes ulcers as well as liver and colon cancer.

Hylton found that when Helicobacter infections are present, they dramatically change the mechanism causing intestinal injury after hemorrhage. Infected mice did not get intestinal damage from complement activation but rather a different component of the immune system was involved.

"Diana found that mice infected with Helicobacter sustain significant intestinal damage in response to hemorrhage, but it is not complement-mediated," Fleming said. "This is important, as many of the therapeutics for hemorrhage are aimed at stopping the complement system, and they do not improve the outcome of infected mice. Thus, trauma patients with undiagnosed infections may require different therapeutics."

Hylton is finishing her central project that involves using a complement inhibitor, administered after hemorrhage, to analyze the changes in the intestinal tissue injury and . The complement inhibitor is delivered locally to the intestinal tissue where complement is activated and binds to certain molecules that have covered the injured cells. This selective binding blocks any further undesirable complement activation that would injure the intestinal tissue.

"I am eager to learn more about how the immune response following hemorrhage is influenced by other immune cells and their secretions," Hylton said. "Cytokines are an exciting area of research because they can have different biological functions in different parts of the body and with different immune responses."

She said initial studies show that IL-12, a small non-antibody molecule that communicates between cells in the body, increases after hemorrhage and is blocked when complement is inhibited. By using mice that are IL-12 deficient, she is studying the pathways and cells involved in IL-12 production after .

Hylton has presented the Helicobacter research at the Annual Meeting of the Society of Leukocyte Biology and at the Annual K-State Research Forum. She presented both the Helicobacter and complement inhibitor research at the Kansas Institutional Development Award Network of Biomedical Research Excellence symposium.

Explore further: West Africa's Ebola outbreak prompts changes in I.Coast cuisine

Related Stories

Flu deaths could be reduced thanks to cancer research

Nov 17, 2008

(PhysOrg.com) -- Cells involved in the body’s immune response to cancer are also implicated in influenza infection and could be targeted in new flu vaccination strategies, scientists at Oxford University ...

Gastric ulcer bacteria turn immune defense inwards

Jan 25, 2010

Despite a strong response from our immune defence, the body is unable to rid itself of the bacterium Helicobacter pylori. One reason for this is that this bacterium encourages elements of the immune response to remain in tis ...

Piece from childhood virus may save soldiers' lives

Sep 06, 2009

A harmless shard from the shell of a common childhood virus may halt a biological process that kills a significant percentage of battlefield casualties, heart attack victims and oxygen-deprived newborns, according to research ...

Research could lead to way to halt deadly immune response

Feb 09, 2010

Researchers have teased out the molecular process that can shut down a marauding, often deadly immune response that kills thousands each year who suffer battlefield casualties, heart attacks, strokes, automobile accidents ...

Recommended for you

Two expats die of MERS in Saudi commercial hub

13 hours ago

Two foreigners died of MERS in the Saudi city of Jeddah, the health ministry said Saturday, as fears rise over the spreading respiratory virus in the kingdom's commercial hub.

UAE reports 12 new cases of MERS

13 hours ago

Health authorities in the United Arab Emirates have announced 12 new cases of infection by the MERS coronavirus, but insisted the patients would be cured within two weeks.

Filipino tests negative for Middle East virus

Apr 19, 2014

A Filipino nurse who tested positive for the Middle East virus has been found free of infection in a subsequent examination after he returned home, Philippine health officials said Saturday.

User comments : 0

More news stories

Less-schooled whites lose longevity, study finds

Barbara Gentry slowly shifts her heavy frame out of a chair and uses a walker to move the dozen feet to a chair not far from the pool table at the Buford Senior Center. Her hair is white and a cough sometimes interrupts her ...

How to keep your fitness goals on track

(HealthDay)—The New Year's resolutions many made to get fit have stalled by now. And one expert thinks that's because many people set their goals too high.

Low tolerance for pain? The reason may be in your genes

Researchers may have identified key genes linked to why some people have a higher tolerance for pain than others, according to a study released today that will be presented at the American Academy of Neurology's 66th Annual ...

Growing app industry has developers racing to keep up

Smartphone application developers say they are challenged by the glut of apps as well as the need to update their software to keep up with evolving phone technology, making creative pricing strategies essential to finding ...

Making graphene in your kitchen

Graphene has been touted as a wonder material—the world's thinnest substance, but super-strong. Now scientists say it is so easy to make you could produce some in your kitchen.